id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S2900 R4091 |
Bérard, 2018 | Major congenital malformations | 1st trimester | nested case control | unexposed (general population or NOS) | Adjustment: Yes | 0.97 [0.81;1.16] | 5/51 14,363/144,265 | 14,368 | 51 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4080 R8677 |
Karadag, 2013 | Major malformations | early pregnancy | retrospective cohort | unexposed, sick | Adjustment: No | 5.00 [0.07;366.35] C | 0/2 0/8 | 0 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13720 R53449 |
Viktil (Controls exposed to other treatments), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester | population based cohort propective | exposed to other treatment, sick excluded | Adjustment: No |
9.30 [0.37;231.05] C excluded (control group) |
0/2 50/1,459 | 50 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S13721 R53451 |
Viktil (Controls unexposed, NOS), 2012 | Major malformations | 3 months or more before pregnancy or1st trimester excluded | population based cohort propective | unexposed (general population or NOS) | Adjustment: No |
10.00 [0.41;245.45] C excluded (exposition period) |
0/2 5,000/154,976 | 5,000 | 2 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2970 R4181 |
Chambers (Unexposed control, disease free), 2010 | Major structural defects (live births and pregnancy losses) | 1st trimester | prospective cohort | unexposed, disease free excluded | Adjustment: No |
1.20 [0.23;6.17] C excluded (control group) |
3/63 3/75 | 6 | 63 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S2969 R4168 |
Chambers (Unexposed control, sick), 2010 | Major structural defects (live births and pregnancy losses) | 1st trimester | prospective cohort | unexposed, sick | Adjustment: No | 0.71 [0.18;2.84] C | 3/63 7/106 | 10 | 63 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 3 studies | 0.97 [0.81;1.16] | 14,378 | 116 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Unexposed control, sick;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 2970, 13720